 |
Recent Accomplishments
In
less than four years, eight Bristol-Myers Squibb
medicines, each addressing a critical medical need, have been
approved. This was among the best performances in the industry
for the period.
As of
September 2006.
Please
click on product names in table above for Important Safety Information.
Please
click on product name to see the Full Prescribing Information
for Abilify®, Reyataz®, Erbitux®, Baraclude®, Orencia®,
EMSAM®, SPRYCEL®,
and
ATRIPLA™ including boxed
WARNINGS for Abilify®, Erbitux®, Baraclude®, EMSAM®,
and
ATRIPLA™.
|
